NOCD, a virtual provider for obsessive-compulsive disorder, launched its new parent brand Noto on Tuesday to help expand into other virtual therapies. It’s starting with post-traumatic stress disorder through its acquisition of Rebound Health, which it also announced on Tuesday.
Chicago-based NOCD virtually connects patients with OCD to therapists who specialize in Exposure and Response Prevention therapy, a type of cognitive behavioral therapy that was created specifically for people with OCD. It works with payers and has a network of over 1,000 therapists.
Noto, which means “to be known” in Latin, is an AI-powered platform that supports payer administrative functions like member identification, enrollment, credentialing and revenue cycle management, while also powering patient engagement through targeted awareness campaigns, community tools and live educational events. On the clinical side, Noto equips therapists with AI-enabled training, clinical interviewing tools, documentation support, outcomes tracking and ongoing oversight.
This technology helped scale NOCD over the last decade, which is why the company chose to launch it as its parent brand to help scale specialty therapy for other complex psychiatric and behavioral conditions.
“Based on the impact Noto has brought NOCD, we feel the responsibility to leverage Noto to scale other virtual specialties for complex, hidden, but highly treatable conditions—starting with Rebound for PTSD. … Imagine a world where 5+ specialties, like NOCD and Rebound, are all powered by Noto, each leveraging operational support for payer partnerships, enrollment, and treatment operations,” said Stephen Smith, CEO and founder of NOCD, in an email.
Rebound Health will now operate as a dedicated specialty under Noto, just like NOCD. Rebound allows patients to meet regularly with a licensed trauma therapist through video sessions, message their therapist between sessions and engage in guided practice between sessions.
Joining Noto provides the company with the infrastructure to scale, according to Rebound’s CEO.
“We founded Rebound to make trauma recovery the norm, not the exception. Survivors deserve access to specialized, evidence-based treatment that supports real recovery, and for too long, that simply hasn’t existed at scale,” said Raeva Kumar, CEO and co-founder of Rebound, in an email. “By joining Noto, we’re able to accelerate our mission and bring proven trauma treatment to millions of survivors through their established infrastructure and technology-enabled platform.”
Rebound will continue to be led by Kumar and co-founder Dr. Erin Berenz.
By launching Noto and acquiring Rebound Health, Smith aims to “end the mental health crisis as we know it,” he said. The company plans to expand into additional specialties in the future.
“Mental illnesses will never go away, but we can end how they’re mismanaged by better diagnosing and treating each condition at scale,” he stated.
Photo: mikdam, Getty Images
